# Adoptive Transfer Of Autologous Tumor-Infiltrating Lymphocytes in Solid Tumors

> **NCT03992326** · PHASE1 · TERMINATED · sponsor: **Centre Hospitalier Universitaire Vaudois** · enrollment: 6 (actual)

## Conditions studied

- Solid Tumor, Adult

## Interventions

- **OTHER:** TIL
- **DRUG:** Cyclophosphamide
- **DRUG:** Fludarabine
- **DRUG:** Interleukin-2
- **OTHER:** Radiotherapy

## Key facts

- **NCT ID:** NCT03992326
- **Lead sponsor:** Centre Hospitalier Universitaire Vaudois
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-09-01
- **Primary completion:** 2021-03-05
- **Final completion:** 2021-03-05
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Internal competitive study that is open
- **Last updated:** 2021-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03992326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03992326, "Adoptive Transfer Of Autologous Tumor-Infiltrating Lymphocytes in Solid Tumors". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03992326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*